
The far-right Alternative for Germany (AfD) on Saturday drew ahead of Chancellor Friedrich Merz's conservatives in a new opinion poll.
Merz's Christian Democratic Union (CDU) and its Bavarian sister party, the Christian Social Union (CSU), dropped by one percentage point to 25% in the INSA poll for the Sunday edition of the Bild newspaper.
The AfD, Germany's largest opposition party, was unchanged from last week's survey on 26%. The anti-immigrant party is under investigation by domestic intelligence services for its extremist views, but surged to second place in the 2025 parliamentary election.
In third place were Merz's centre-left coalition partners in the Social Democratic Party (SPD), down one point to 13%.
The opposition Greens and The Left were also unchanged at 12% and 11% respectively.
The margin of error was 2.9 percentage points, with 1,199 respondents participating in the survey.
latest_posts
- 1
COGAT discovers motor oil hidden inside UN's humanitarian aid to Gaza in smuggling attempt - 2
Bayer reports positive results for blood thinner after 2023 setback - 3
The cave was pitch black – so to create this magical underwater shot, the photographer had to use all his camera expertise... - 4
German unemployment rate falls to 6.4%, but 3 million still jobless - 5
Ukraine's naval drones are gunning for Russia's 'shadow fleet.' A security source says a tanker just suffered a critical hit.
New findings suggest atmosphere could exist on exoplanet TOI-561b
Full Supreme Court to hear challenge to Judicial Selection Committee law
These 3 Nail-Free Finds Completely Transformed My Drab Bathroom
Whale stranded in the Baltic Sea swims free again. It still faces a tough task
The most effective method to Shield Your Gold Ventures: Procedures and Precautionary measures
How much would you pay to meet a Real Housewife? At BravoCon, the limit does not exist.
Moving Wedding Objections for Paramount Functions
Mosquitoes carrying malaria are evolving more quickly than insecticides can kill them – researchers pinpoint how
AstraZeneca to invest $2 billion as part of US manufacturing push













